Showing results (241-250 of 254) with videos related to
Sort By:
Pageof 26
Clinical and Experimental Rheumatology|September 29, 2015
Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER networkH Che, A Etcheto, E Dernis, et al.Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK propertiesMaria V Sergeeva, Yuefen Zhou, Darian M Bartkowski, et al.Nature Communications|November 27, 2014
Community-integrated omics links dominance of a microbial generalist to fine-tuned resource usageEmilie E L Muller, Nicolás Pinel, Cédric C Laczny, et al.Nature Microbiology|November 3, 2020
Roles of bacteriophages, plasmids and CRISPR immunity in microbial community dynamics revealed using time-series integrated meta-omicsSusana Martínez Arbas, Shaman Narayanasamy, Malte Herold, et al.Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Stephen E Webber, Martin T Tran, et al.Microbiome|October 7, 2025
Integrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson's diseaseRémy Villette, Júlia Ortís Sunyer, Polina V Novikova, et al.Journal of Medicinal Chemistry|March 5, 2020
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple MyelomaJoshua D Hansen, Matthew Correa, Mark A Nagy, et al.Nature Communications|October 20, 2020
Integration of time-series meta-omics data reveals how microbial ecosystems respond to disturbanceMalte Herold, Susana Martínez Arbas, Shaman Narayanasamy, et al.Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymeraseSun Hee Kim, Martin T Tran, Frank Ruebsam, et al.Bioorganic & Medicinal Chemistry Letters|May 7, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessmentsLian-Sheng Li, Yuefen Zhou, Douglas E Murphy, et al.Pageof 26